Grace Therapeutics, Inc. - Common Stock (NQ: GRCE )

2.180 -0.110 (-4.80%)

Streaming Delayed Price Updated: 3:32 PM EDT, Mar 14, 2025 Add to My Watchlist

Price and Volume

Volume	55,080
Open	2.240
Bid (Size)	2.180 (3)
Ask (Size)	2.280 (1)
Prev. Close	2.290
Today's Range	2.070 - 2.262
52wk Range	2.070 - 4.965
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors

March 11, 2025

From Matinas BioPharma Holdings, Inc.

Via GlobeNewswire

Small-Cap Grace Therapeutics Touts Positive Data From Brain Hemorrhage Study

February 10, 2025

Grace Therapeutics' GTx-104 met its Phase 3 trial endpoint, showing clinical benefits over oral nimodipine. US NDA submission is expected in early 2025.

Via Benzinga

Performance

YTD	-45.50%	-45.50%
1 Month	-37.27%	-37.27%
3 Month	-39.11%	-39.11%
6 Month	-32.09%	-32.09%
1 Year	-32.09%	-32.09%

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.

Grace Therapeutics, Inc. - Common Stock (NQ: GRCE )

Price and Volume

Top News

Performance

Information